How much funding has Thalya raised?

Thalya has raised $4.0M in total funding, most recently a Seed round.

Who are Thalya's investors?

Thalya's investors include Entrepreneur First, Transpose Platform Management, Ring Capital, Y Combinator Continuity Fund.

Where is Thalya headquartered?

Thalya is headquartered in Évry-Courcouronnes, France.

Thalya

Évry-Courcouronnes, France · Founded 2024 · $4.0M raised

Biotech

Headquarters: Évry-Courcouronnes
Employees: 1–10
Founded: 2024
Business Model: B2B

Website: thalya.bio
Total Funding: $4.0M
Last Round: $4.0M SeedSep 2024
Rounds: 1

About

Thalya is a French biotechnology company founded in August 2024 within the Entrepreneur First incubator, developing RNAi spray technology designed to improve nitrogen uptake in crops. The company's solution aims to unlock approximately $250 billion annually for farmers while reducing global greenhouse gas emissions by 4%. Thalya has signed proof-of-concept contracts covering 320 acres of land in key US corn-producing states and is backed by Y Combinator.

Summary

Thalya is a Biotech company based in Évry-Courcouronnes, France, founded in 2024. It has raised $4.0M in total across 1 round, most recently a $4.0M Seed round in Sep 2024. Investors include Entrepreneur First, Transpose Platform Management and Ring Capital.